Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
02/2003
02/26/2003EP1285063A1 Anti-angiogenic polypeptides
02/26/2003EP1285061A1 Antisense modulation of pten expression
02/26/2003EP1285060A2 26335, a novel human serine/threonine dehydratase and uses thereof
02/26/2003EP1285059A2 Adjuvant preparation for the induction of specific immunity
02/26/2003EP1285058A2 Fertilization of aged oocytes
02/26/2003EP1285004A1 Synthetic peptides and uses therefore
02/26/2003EP1285002A2 REGULATING LIPID LEVELS VIA THE i ZMAX1 /i OR i HBM /i GENE
02/26/2003EP1285001A1 Methods for identifying modulators of the interaction between lap (latency associated peptide) and integrin alpha.v.beta.3 and medical use thereof
02/26/2003EP1285000A2 Use of adnf for enhancing learning and memory
02/26/2003EP1284999A2 Repair of nerve damage
02/26/2003EP1284997A2 Therapeutic compounds for ovarian cancer
02/26/2003EP1284996A2 Therapeutic anti-melanoma compounds
02/26/2003EP1284994A2 Use a high-molecular-weight extracellular haemoglobin as blood substitute
02/26/2003EP1284992A2 Polyubiquitin based hydrogel and uses thereof
02/26/2003EP1284988A1 Laminin 15 and uses thereof
02/26/2003EP1284753A2 Combination of growth hormone secretagogues and antidepressants
02/26/2003EP1284752A1 Bispecific molecules and uses thereof
02/26/2003EP1284750A1 Pharmaceutical composition
02/26/2003EP1284749A2 Use of hyaluronidase for preventing and treating cardio vascular diseases
02/26/2003EP1284748A1 Treatment of damaged connective tissue
02/26/2003EP1284747A2 Compositions and methods for achieving immune suppression
02/26/2003EP1284746A1 A method of treatment and prophylaxis
02/26/2003EP1284741A2 3'-or 2'-hydroxymethyl substituted nucleoside derivatives for treatment of hepatitis virus infections
02/26/2003EP1284720A2 Method of treating hepatitis delta viral infection
02/26/2003EP1284719A2 The use of a calcium channel blocker for treating renal disorders
02/26/2003EP1237563A4 Nutritional composition, methods of producing said composition and methods of using said composition
02/26/2003EP1153615B1 Pharmaceutical formulation for intravenous or intramuscular octreotide administration
02/26/2003EP1150976B1 3-(thio-substituted amido)-lactams useful as inhibitors of matrix metalloproteinase
02/26/2003EP1052998A4 Compositions and methods for modulating cytokine release in response to genotoxic agents
02/26/2003EP1028746B1 Method for producing igf-i sustained-release formulations
02/26/2003EP1021424B1 Thiadiazole amide mmp inhibitors
02/26/2003EP1015568B1 METHOD FOR THE PRODUCTION OF rDSPA Alpha1
02/26/2003EP0946169B1 Method of producing a sustained-release preparation
02/26/2003EP0944396B1 Compositions and methods for enhancing intestinal function
02/26/2003EP0941235B1 Cyclic peptides that bind to urokinase-type plasminogen activator receptor
02/26/2003EP0929571B1 4-substituted-3-(2-amino-2-cycloalkyl methyl)-acetamido azetidin-2-one derivatives as cysteine proteinase regulators
02/26/2003EP0896544B1 Combination of a somatostatin analogue and a rapamycin
02/26/2003EP0832068B1 Stable reagents for the preparation of radiopharmaceuticals
02/26/2003EP0822986B1 Antagonists of human interleukin-6 that are totally incapable of binding gp 130, and their use in the preparation of pharmaceutical compounds
02/26/2003EP0797448B1 Combination preparation, containing cyclosporin a or fk506 or rapamycin and a xanthine derivative
02/26/2003EP0770137B1 Improvements in production of proteins in host cells
02/26/2003EP0759943B1 Monoclonal antibody specific for vascular endothelial cell antigen endoglyx-1, the antigen itself, and uses thereof
02/26/2003EP0710114B1 A coagulation factor viii formulation
02/26/2003EP0672140B1 TRANSFECTED CELL LINE EXPRESSING cDNAs ENCODING HUMAN NMDA-R2A RECEPTOR SUBUNIT AND ISOFORMS OF THE HUMAN NMDA-R1 RECEPTOR SUBUNIT
02/26/2003CN1399680A 上皮细胞生长抑制剂 Epithelial cell growth inhibitor
02/26/2003CN1399678A Human Enzymes of metalloprotease family
02/26/2003CN1399646A Recombinant fusion molecules
02/26/2003CN1399644A Novel human G-Protein coupled receptor
02/26/2003CN1399643A Primary nucleotide sequence of shrimp white spot bacilliform virus (WSBV), discovery system containing this sequence and detection kit and antiviral targets for detection and controlling shrimp
02/26/2003CN1399562A Method of treating lupus based on antibody affinity and screening methods and compositions for use thereof
02/26/2003CN1399561A Conjugate having cleavable linkage for use in liposome
02/26/2003CN1399560A Novel albumin-free factor VIII formulations
02/26/2003CN1399557A Remedies for drug-resistant hypercalcemia
02/26/2003CN1399556A APRIL receptor (BCMA) and uses thereof
02/26/2003CN1399555A Use of protein UK114 for inhibiting organ transplant rejection
02/26/2003CN1399554A Method and compositions for inhibiting adhesion formation
02/26/2003CN1399552A Method and composition for treatment of adenoviral ocular infections
02/26/2003CN1399541A Colloidal suspension of submicronic particles as vectors for active principles and method for preparing same
02/26/2003CN1398969A Prepn of modification enzyme for earthworm fibrinolysin
02/26/2003CN1398899A Recombinant thymin alpha-1 and its prepn
02/26/2003CN1398897A Serial synthetic antibacterial peptide
02/26/2003CN1398896A Hybrid peptide with vascularization inhibiting activity
02/26/2003CN1398895A Hypoxic inducing factor-1 relative peptide and its screening
02/26/2003CN1398894A Bioactive peptide No.26
02/26/2003CN1398893A Bioactive peptide No.27
02/26/2003CN1398892A Bioactive peptide No.28
02/26/2003CN1398891A Bioactive peptide No.12
02/26/2003CN1398890A Bioactive peptide No.13
02/26/2003CN1398889A Bioactive peptide No.18
02/26/2003CN1398888A Bioactive peptide No.29
02/26/2003CN1398887A Bioactive peptide No.11
02/26/2003CN1398886A Bioactive peptide No.17
02/26/2003CN1398885A Bioactive peptide No.7
02/26/2003CN1398884A Bioactive peptide No.30
02/26/2003CN1398883A Bioactive peptide No.24
02/26/2003CN1398882A Bioactive peptide No.21
02/26/2003CN1398881A Bioactive peptide No.23
02/26/2003CN1398880A Bioactive peptide No.22
02/26/2003CN1398879A Bioactive peptide No.14
02/26/2003CN1398878A Bioactive peptide No.16
02/26/2003CN1398877A Bioactive peptide No.15
02/26/2003CN1398645A Composite transplant containing concanavalin A and its prepn and application
02/26/2003CN1398637A Thymosin alpha-1 microball prepn and its prepn process
02/26/2003CN1398636A Thymosin composition injection and its prepn
02/26/2003CN1398635A Piracetam medicine composition with function of promoting thinking and memory and its prepn
02/26/2003CN1398585A Slow-releasing bFGF-PLA-PEG microball and its prepn and use
02/26/2003CN1398584A Slow-releasing bFGF-PLGA microball and its prepn and use
02/26/2003CN1102174C Ribozyme
02/26/2003CA2420656A1 Antisense oligonucleotides against vanilloid receptor 1
02/25/2003USRE38008 Peptides hormones, steroid hormones and conjugates thereof are disclosed. Enhanced delivery to target cells of antibodies or fragments thereof or other receptor-mediated delivery system, such as peptide, specific for a population of cells of a
02/25/2003US6525241 Expression methods
02/25/2003US6525188 Nuclear receptor of given amino acid sequence; receptor modulates 9-cis retinoic acid signalling
02/25/2003US6525187 Polynucleotide encoding autoantigens associated with endometriosis
02/25/2003US6525184 Self-regulated apoptosis of inflammatory cells
02/25/2003US6525179 Methods and compositions for impairing multiplication of HIV-1
02/25/2003US6525178 PGC-1, a novel brown fat PPARgamma coactivator
02/25/2003US6525177 Truncated forms of NY-ESO-1 protein
02/25/2003US6525174 Precerebellin-like protein
02/25/2003US6525102 Increasing storage stability of interleukin-2 by incorporating free base form arginine and succinic acid
02/25/2003US6525076 Selective factor Xa inhibitors
1 ... 1899 1900 1901 1902 1903 1904 1905 1906 1907 1908 1909 1910 1911 1912 1913 1914 1915 1916 1917 1918 1919 ... 3163